Rare diseases
Investigational molecules
Locations
Back to France785 clinical trials in Chambery, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Sibeprenlimab for Patients with IgA Nephropathy
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
FranceStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
FranceStudy of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer
FranceStudy Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
FranceStudy on Bulevirtide Treatment for Patients with Chronic Hepatitis D
FranceStudy on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis
FranceStudy on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
FranceLong-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia
FranceStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel therapeutic combinations and treatment strategies.
Advanced trials exploring combinations of immunotherapy and targeted treatments for blood cancers.
Studies examining innovative treatments for non-small cell lung cancer, particularly focusing on immunotherapy approaches.
Emphasis on improving treatment outcomes through targeted and combination therapies.
Research on pneumococcal vaccines and preventive treatments, including studies in specialized patient populations.
Focus on vaccine effectiveness during acute illness conditions.
Clinical trials examining treatments for hormone-sensitive breast cancer, including targeted therapies and hormone treatment optimization.
Investigation of personalized treatment approaches based on molecular markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
